Related Experiment Video
Updated: Aug 19, 2026

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
Published on: October 16, 2021
Electromechanical activation and recovery wave imaging for pediatric mitral valve disease characterization
Melina Tourni1, Christina Proestaki1, Seungyeon Julia Han1
1Department of Biomedical Engineering, Columbia University, New York, NY 10027.
Insights
Electromechanical Wave Imaging (EWI) detects early electrical changes in pediatric mitral valve disease, identifying delayed activation and recovery linked to arrhythmia risk. This advanced echocardiography offers new insights into cardiac electromechanics.
Area of Science:
- Cardiology
- Biomedical Engineering
- Medical Imaging
Background:
- Mitral valve (MV) disease, including prolapse (MVP) and regurgitation (MR), affects 2-5% of the population and is linked to significant arrhythmogenic risk.
- Pediatric MVP and MR can reveal early electromechanical alterations, crucial for understanding arrhythmia mechanisms and sudden cardiac death.
- Conventional echocardiography has limited sensitivity for assessing MV electromechanics, necessitating advanced imaging techniques.
Purpose of the Study:
- To introduce and validate Electromechanical Wave Imaging (EWI) for mapping MV-complex activation and diastolic recovery in pediatric subjects.
- To investigate the electromechanical differences between pediatric patients with MVP/MR and healthy controls.
- To assess EWI's potential for identifying arrhythmogenic substrates in MVP patients.
Main Methods:
- EWI, a high-frame-rate echocardiography technique, was used to map electromechanical activity in 21 pediatric MVP, MR, and control subjects.
- A preclinical canine study (n=3) established EWI's capability to track electromechanical wave propagation across the atrioventricular junction.
- Analysis focused on left ventricular (LV) activation times and LV recovery intervals.
Main Results:
- MVP patients showed significantly delayed LV activation (76.04 ± 12.51 ms) compared to controls (47.64 ± 2.57 ms), particularly in papillary muscles.
- Both MVP and MR-only subjects exhibited prolonged LV recovery; MR-only patients had significantly longer recovery intervals (277.0 ± 27.61 ms) than controls (248.7 ± 10.43 ms).
- In two arrhythmogenic MVP cases, EWI identified arrhythmic exit sites near LV papillary muscles, correlating with delayed sinus activation.
Conclusions:
- Atrioventricular valve function significantly influences cardiac electromechanical function.
- Full-cycle EWI is a transformative noninvasive tool for diagnosing MV disease electromechanical effects and assessing arrhythmia risk.
- EWI can guide interventions and advance cardiac imaging for patients with mitral valve disease.
Abstract:
Mitral valve (MV) disease, particularly MV prolapse (MVP) and mitral regurgitation (MR), affects 2 to 5% of the population and poses a substantial arrhythmogenic risk, with 43% of MVP patients developing arrhythmias. Although less common in children, the absence of comorbidities can uniquely isolate early electromechanical alterations that may elucidate mechanisms later contributing to arrhythmic risk and devastating effects such as sudden cardiac death. Conventional echocardiography lacks sensitivity for MV electromechanics, motivating advanced approaches. We introduce Electromechanical Wave Imaging (EWI), a high-frame-rate echocardiography modality, to map MV-complex activation and diastolic recovery in N = 21 MVP, MR, and control pediatric subjects (13.10 ± 4.51 y old, 43% male). A preclinical canine study (n = 3) established EWI's ability to observe temporally coupled electromechanical wave propagation across the atrioventricular junction through the closed MV-following atrial and preceding ventricular activation (73.0 ms, 60 BPM). MVP patients exhibited significantly delayed left ventricular (LV) activation (76.04 ± 12.51 ms vs. 47.64 ± 2.57 ms in controls, P = 0.0013), primarily in papillary muscles. Both MVP and MR-only subjects exhibited prolonged LV recovery, with MR-only patients showing significantly longer recovery intervals (MR-only: 277.0 ± 27.61 ms, Control: 248.7 ± 10.43 ms, MVP vs. Control: MR-only vs. Control: P = 0.0395). In two arrhythmogenic MVP cases, EWI localized arrhythmic exit sites adjacent to LV papillary muscles, coinciding with regional delayed sinus activation, aligning with invasive electrophysiology. This study demonstrates that atrioventricular valve function dictates cardiac electromechanical function and establishes full-cycle EWI as a transformative tool for diagnosing MV disease electromechanical effects, assessing arrhythmic risk, guiding interventions, and advancing noninvasive cardiac imaging.
Related Concept Videos
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral Regurgitation II: Clinical Features and Diagnostic Tests
Mitral Valve Prolapse II: Assessment and Management
Imaging Studies for Cardiovascular System I:Echocardiography
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion, evaluates...